Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670916 | 0.92 | KCNH2 (0.39) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| SCHEMBL15992996 | 0.92 | KCNH2 (0.39) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| SCHEMBL16196389 | 0.89 | GGPS1 (0.39) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| SCHEMBL28633185 | 0.89 | GGPS1 (0.39) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| Sulfuric Acid SCHEMBL29142282 | 0.88 | LMNA (0.46) | GGPS1LMNAL3MBTL1PABPC1KMT2A | |
| Trifluoromethanesulfonic Acid SCHEMBL30330385 | 0.88 | KCNH2 (0.46) | KCNH2GGPS1LMNAL3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL306405 | 0.88 | KCNH2 (0.46) | KCNH2GGPS1LMNAL3MBTL1 | |
| SCHEMBL15993134 | 0.87 | GGPS1 (0.37) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| SCHEMBL29377105 | 0.87 | GGPS1 (0.37) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| SCHEMBL1461724 | 0.86 | LMNA (0.45) | GGPS1LMNAL3MBTL1PABPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3244987-B1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2022-06-22 | — | — | EP | claimed |
| EP-3244987-A1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | Chevron Phillips Chemical Company LP (US) | 2017-11-22 | — | — | EP | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | claimed |
| WO-2025047318-A1 | SURFACE PROTECTION FILM | 日東電工株式会社 | 2025-03-06 | — | — | WO | disclosed |
| CN-114716944-B | Surface protective film | 日东电工株式会社 | 2025-02-25 | — | — | CN | disclosed |
| CN-117210145-A | Antistatic surface protection film | 浙江东柔新材料有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117126618-A | Adhesive film for foldable display | 浙江东柔新材料有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117050673-A | Surface protective film | 日东电工株式会社 | 2023-11-14 | — | — | CN | disclosed |
| CN-117050672-A | Surface protective film | 日东电工株式会社 | 2023-11-14 | — | — | CN | disclosed |
| CN-116685468-A | Surface protective film | 日东电工株式会社 | 2023-09-01 | — | — | CN | disclosed |
| CN-116670242-A | Surface protective film | 日东电工株式会社 | 2023-08-29 | — | — | CN | disclosed |
| US-20140272408-A1 | WATER-DISPERSIBLE ACRYLIC PRESSURE-SENSITIVE ADHESIVE COMPOSITION, PRESSURE-SENSITIVE ADHESIVE LAYER, AND PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORPORATION (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140248490-A1 | REMOVABLE WATER-DISPERSIBLE ACRYLIC PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORPORATION (JP) | 2014-09-04 | — | — | US | disclosed |
| WO-2014067603-A1 | SALTS WITH TRIHYDROPERFLUOROALKOXYBUTANE SULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANE SULFONATE ANION | MERCK PATENT GMBH (DE) | 2014-05-08 | — | — | WO | disclosed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-7691180-B2 | Mixtures of ionic liquids with lewis acids | NOVARTIS AG (CH) | 2010-04-06 | — | — | US | disclosed |
| US-20060264642-A1 | Mixtures of ionic liquids with lewis acids | NOVARTIS AG (CH) | 2006-11-23 | — | — | US | disclosed |
| EP-1658268-A1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | Novartis AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005014547-A1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264642-A1 | Mixtures of ionic liquids with lewis acids | NRAS, KRAS, SSB | KCNH2 2217/4885GGPS1 2623/4885LMNA 2021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.